Membranous nephropathy: pathogenesis and treatments
MedComm · 2024-07 · 5 (7)
DOI: 10.1002/mco2.614 ↗At a glance
Übersichtsarbeit in MedComm, published online on 2024-06-29. Written by Mengqiong Wang and 4 co-authors. Institution: Department of Nephrology Center for Regeneration and Aging Medicine The Fourth Affiliated Hospital of School of Medicine and International School of …. Cited 40 times so far (Crossref); 245 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents.
Abstract (original language)
Membranous nephropathy (MN), an autoimmune disease, can manifest at any age and is among the most common causes of nephrotic syndrome in adults. In 80% of cases, the specific etiology of MN remains unknown, while the remaining cases are linked to drug use or underlying conditions like systemic lupus erythematosus, hepatitis B virus, or malignancy. Although about one‐third of patients may achieve spontaneous complete or partial remission with conservative management, another third face an elevated risk of disease progression, potentially leading to end‐stage renal disease within 10 years. The identification of phospholipase A2 receptor as the primary target antigen in MN has brought about a significant shift in disease management and monitoring. This review explores recent advancements in the pathophysiology of MN, encompassing pathogenesis, clinical presentations, diagnostic criteria, treatment options, and prognosis, with a focus on emerging developments in pathogenesis and therapeutic strategies aimed at halting disease progression. By synthesizing the latest research findings and clinical insights, this review seeks to contribute to the ongoing efforts to enhance our understanding and management of this challenging autoimmune disorder.
Subjects
Author keywords
Authors and institutions
- Department of Nephrology Center for Regeneration and Aging Medicine The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine Zhejiang University Yiw…
Funding
- National Natural Science Foundation of China
- Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
Cite
APA
Wang, M., Yang, J., Fang, X., Lin, W., & Yang, Y. (2024). Membranous nephropathy: pathogenesis and treatments. MedComm, 5(7). https://doi.org/10.1002/mco2.614
Vancouver
Wang M, Yang J, Fang X, Lin W, Yang Y. Membranous nephropathy: pathogenesis and treatments. MedComm. 2024;5(7). doi:10.1002/mco2.614
BibTeX
@article{Wang2024,
author = {Wang, Mengqiong and Yang, Jingjuan and Fang, Xin and Lin, Weiqiang and Yang, Yi},
title = {Membranous nephropathy: pathogenesis and treatments},
journal = {MedComm},
year = {2024},
volume = {5},
number = {7},
doi = {10.1002/mco2.614}
}
EUVIMED